Drug search by name
Ibritumomab Intravenous and Kisqali (600 MG Dose)
Determining the interaction of Ibritumomab Intravenous and Kisqali (600 MG Dose) and the possibility of their joint administration.
Check result:
Ibritumomab Intravenous <> Kisqali (600 MG Dose)
Relevance: 18.02.2023
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Ibritumomab Intravenous
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Kisqali (600 MG Dose)
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Ibritumomab Intravenous-Kisqali Femara Co-Pack
- Ibritumomab Intravenous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Ibritumomab Intravenous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Ibritumomab Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Ibritumomab Intravenous-Kitabis Pak
- Ibritumomab Intravenous-Kitabis Pak inhalation
- Kisqali (600 MG Dose)-Ibritumomab Tiuxetan
- Kisqali (600 MG Dose)-Ibrutinib
- Kisqali (600 MG Dose)-Ibrutinib Capsules
- Kisqali (600 MG Dose)-Ibrutinib Tablets
- Kisqali (600 MG Dose)-Ibu
- Kisqali (600 MG Dose)-IBU Tablets
Doktika World
Interaction with food and lifestyle
Disease interaction